Rudy Li Stock Analyst Profile - Chardan Capital Research Coverage - Stocknear

Rudy Li

Stock Analyst at Chardan Capital

(5)
# 141
Out of 5,506 analysts
28
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:

10 Stocks

Name Action PT Current % Upside Ratings Updated
IMUX Immunic
Initiates Coverage On: Buy
3
0.98 206.12% 1 Sep 29, 2025
ANRO Alto Neuroscience
Initiates Coverage On: Buy
15
6.9 117.39% 1 Sep 29, 2025
RVPH Reviva Pharmaceutica...
Initiates Coverage On: Buy
2
n/a n/a 1 Sep 29, 2025
PRTA Prothena Corp
Maintains: Buy
18 18
9.92 81.45% 7 Aug 28, 2025
STOK Stoke Therapeutics
Maintains: Buy
24 24
25.56 -6.1% 4 Aug 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
55 55
39.61 38.85% 3 Aug 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
30 30
23.23 29.14% 3 Aug 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 20
12.56 59.24% 4 Aug 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
80 80
54.38 47.11% 2 Jul 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
80 80
53.26 50.21% 2 May 21, 2025